Study on apoptosis effect of human breast cancer cell MCF-7 induced by lycorine hydrochloride via death receptor pathway

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Breast cancer remains a leading cause of mortality in women worldwide.
• Identifying novel therapeutic agents targeting cancer cell apoptosis is crucial.
• Lycorine, a natural alkaloid, has demonstrated potential anti-cancer properties.

Purpose of the Study:

• To investigate the effect of lycorine hydrochloride on early apoptosis in human breast cancer cells (MCF-7).
• To examine the expression of key apoptosis-related proteins (Fas, FasL, Caspase-8, Bid) in response to lycorine hydrochloride treatment.
• To elucidate the underlying mechanism of lycorine hydrochloride-induced apoptosis in MCF-7 cells.

Main Methods:

• AnnexinV/PI double staining and flow cytometry were employed to quantify early apoptosis rates.
• Western Blotting was utilized to assess the protein expression levels of Fas, FasL, Caspase-8, and Bid.
• Experiments were conducted using varying concentrations of lycorine hydrochloride to evaluate dose-dependency.

Main Results:

• Lycorine hydrochloride significantly increased the apoptosis rate of MCF-7 cells in a dose-dependent manner.
• The expression and activity of Fas, FasL, Caspase-8, and Bid proteins were elevated with increasing lycorine hydrochloride dosage.
• While apoptosis rate was dose-dependent, protein activity showed some degree of dose-independence.

Conclusions:

• Lycorine hydrochloride effectively induces early apoptosis in human breast cancer MCF-7 cells.
• The mechanism involves the activation of the death receptor pathway, including Fas, FasL, Caspase-8, and Bid.
• Lycorine hydrochloride represents a potential therapeutic candidate for breast cancer treatment.